Article may be outdated

This article is 7 days old. Some details may have changed since publication.

Oncodaily·2 min read·hard

New Research Explores the Cost of Managing Brain Metastases in ALK

L
Lusine Tadevosyan
New Research Explores the Cost of Managing Brain Metastases in ALK
AI Summary

New research published in Lung Cancer Management explores the economic and quality-of-life costs of managing brain metastases in ALK-positive lung cancer patients. The study aims to help health systems better understand the value of preventative care.

Oncogene Cancer Research shared on LinkedIn :

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in